📊 Analyst Consensus & Targets
- Analyst Rating: Buy
- Price Target: $1093.2229
- Sector: Healthcare – Drug Manufacturers – General
💡 The Growth Thesis
Buy Consensus: Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. Analysts project a 1.7% potential upside. Currently trading at a Forward P/E of 32.931732.